Denali Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 13.83 M | $188.09 M | -0.61% | 8.08% |
BAILLIE GIFFORD & CO | 05/07/2025 | 12.09 M | $164.36 M | -1.82% | 7.06% |
VANGUARD GROUP INC | 05/09/2025 | 11.80 M | $160.42 M | -1.84% | 6.89% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 11.41 M | $155.11 M | 15.86% | 6.66% |
FMR LLC | 05/12/2025 | 7.41 M | $100.78 M | -7.56% | 4.33% |
UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 6.77 M | $92.00 M | 88.87% | 3.95% |
TEMASEK HOLDINGS (PRIVATE) LTD | 05/16/2025 | 5.36 M | $72.81 M | 0.00% | 3.13% |
CAPITAL RESEARCH GLOBAL INVESTORS | 05/12/2025 | 4.77 M | $64.78 M | -13.00% | 2.78% |
STATE STREET CORP | 05/15/2025 | 4.46 M | $60.64 M | -1.85% | 2.61% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 4.37 M | $59.37 M | 42.78% | 2.55% |
CRESTLINE MANAGEMENT, LP | 05/15/2025 | 4.16 M | $56.57 B | -3.48% | 2.43% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 3.73 M | $50.73 M | 0.00% | 2.18% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 3.15 M | $42.88 M | -4.86% | 1.84% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 3.04 M | $41.30 M | 3.47% | 1.77% |
MARSHALL WACE, LLP | 05/15/2025 | 2.19 M | $29.76 M | 22.34% | 1.28% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 2.10 M | $28.57 M | 13.25% | 1.23% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 1.67 M | $22.73 M | 58.11% | 0.98% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 1.49 M | $20.30 M | 269.37% | 0.87% |
FISHER ASSET MANAGEMENT, LLC | 05/14/2025 | 1.36 M | $18.56 M | 72.23% | 0.80% |
MORGAN STANLEY | 05/15/2025 | 1.25 M | $17.04 M | 1.99% | 0.73% |
CAMBER CAPITAL MANAGEMENT LP | 05/15/2025 | 1.25 M | $16.99 M | -44.44% | 0.73% |
CITADEL ADVISORS LLC | 05/15/2025 | 1.17 M | $15.90 M | 40.94% | 0.68% |
NORTHERN TRUST CORP | 05/13/2025 | 1.13 M | $15.39 M | -5.77% | 0.66% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 1.10 M | $15.01 M | -11.19% | 0.64% |
PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 1.08 M | $14.70 M | -4.37% | 0.63% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.01 M | $13.73 M | -1.81% | 0.59% |
CASDIN CAPITAL, LLC | 05/15/2025 | 990.00 K | $13.46 M | 0.00% | 0.58% |
CANDRIAM S.C.A. | 05/14/2025 | 858.16 K | $11.67 M | 3.02% | 0.50% |
SIREN, L.L.C. | 05/23/2025 | 821.51 K | $11.17 M | -1.50% | 0.48% |
UBS GROUP AG | 05/13/2025 | 788.43 K | $10.72 M | -7.55% | 0.46% |
ABRDN PLC | 05/13/2025 | 759.82 K | $10.33 M | 88.88% | 0.44% |
SQUAREPOINT OPS LLC | 05/15/2025 | 687.15 K | $9.34 M | 1,313.34% | 0.40% |
STEMPOINT CAPITAL LP | 05/15/2025 | 667.08 K | $9.07 M | 14.16% | 0.39% |
CERCANO MANAGEMENT LLC | 05/13/2025 | 625.00 K | $8.50 M | 0.00% | 0.37% |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/14/2025 | 612.44 K | $8.33 M | -41.92% | 0.36% |
ENSIGN PEAK ADVISORS, INC | 05/14/2025 | 587.79 K | $7.99 M | 69.73% | 0.34% |
YIHENG CAPITAL MANAGEMENT, L.P. | 05/16/2025 | 469.98 K | $6.39 M | -32.87% | 0.27% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 447.76 K | $6.09 M | 65.63% | 0.26% |
CLARIUS GROUP, LLC | 04/18/2025 | 369.00 K | $5.02 M | -10.00% | 0.22% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 349.42 K | $4.75 M | -27.28% | 0.20% |
PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 343.96 K | $5.06 M | 1,677.01% | 0.20% |
PIER CAPITAL, LLC | 05/13/2025 | 335.50 K | $4.56 M | 0.96% | 0.20% |
05/12/2025 | 322.95 K | $4.39 M | 100.00% | 0.19% | |
TD ASSET MANAGEMENT INC | 05/07/2025 | 308.58 K | $4.20 M | 16.12% | 0.18% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 301.97 K | $4.11 M | 100.00% | 0.18% |
AXA S.A. | 05/15/2025 | 293.38 K | $3.99 M | -0.13% | 0.17% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 05/13/2025 | 291.80 K | $4.31 M | 17.75% | 0.17% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 288.22 K | $3.92 M | -7.48% | 0.17% |
SEGALL BRYANT & HAMILL, LLC | 05/02/2025 | 281.14 K | $3.82 M | -2.75% | 0.16% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2025 | 258.13 K | $3.51 M | 23.79% | 0.15% |
Denali Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 273 institutional investors and hedge funds held shares of Denali Therapeutics Inc.. The most heavily invested institutionals were:
Riverview Trust Co: 0
DiNuzzo Private Wealth, Inc.: 0
Global Financial Private Client, LLC: 0
BlackRock, Inc.: 13.83 M
BAILLIE GIFFORD & CO: 12.09 M
VANGUARD GROUP INC: 11.8 M
77.45% of Denali Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 151.10 M shares in the last 24 months. This purchase volume represents approximately $2.19 B in transactions.